Literature DB >> 1703362

Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.

L Mieles1, R D Gordon, D Mintz, R M Toussaint, O Imventarza, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1703362      PMCID： PMC3022519     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  27 in total

1.  Transplantation.

Authors:  T E Starzl; J J Fung
Journal:  JAMA       Date:  1990-05-16       Impact factor: 56.272

2.  A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.

Authors:  J J Siekierka; S H Hung; M Poe; C S Lin; N H Sigal
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

3.  Kidney transplantation under FK 506.

Authors:  T E Starzl; J Fung; M Jordan; R Shapiro; A Tzakis; J McCauley; J Johnston; Y Iwaki; A Jain; M Alessiani
Journal:  JAMA       Date:  1990-07-04       Impact factor: 56.272

4.  Morphological and functional changes of pancreatic B cells in cyclosporin A-treated rats.

Authors:  U Helmchen; W E Schmidt; E G Siegel; W Creutzfeldt
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

5.  Pancreatic islet transplantation in cynomolgus monkeys. Initial studies and evidence that cyclosporine impairs glucose tolerance in normal monkeys.

Authors:  M D Stegall; J Chabot; C Weber; K Reemtsma; M A Hardy
Journal:  Transplantation       Date:  1989-12       Impact factor: 4.939

6.  Cyclosporine: action, pharmacokinetics, and effect in the BB rat model.

Authors:  C R Stiller; A Laupacis; P A Keown; C Gardell; J Dupre; P Thibert; W Wall
Journal:  Metabolism       Date:  1983-07       Impact factor: 8.694

7.  A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients.

Authors:  T J Schroeder; M E Brunson; A J Pesce; L L Hindenlang; P A Mauser; D I Ruckrigl; M L Weibel; G Wadih; M R First
Journal:  Transplantation       Date:  1989-02       Impact factor: 4.939

8.  Pancreatic islet transplantation after upper abdominal exenteration and liver replacement.

Authors:  A G Tzakis; C Ricordi; R Alejandro; Y Zeng; J J Fung; S Todo; A J Demetris; D H Mintz; T E Starzl
Journal:  Lancet       Date:  1990-08-18       Impact factor: 79.321

9.  The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomerase.

Authors:  G Fischer; H Bang
Journal:  Biochim Biophys Acta       Date:  1985-03-22

10.  Effects of cyclosporin on insulin and C-peptide secretion in healthy beagles.

Authors:  R Alejandro; E C Feldman; A D Bloom; N S Kenyon
Journal:  Diabetes       Date:  1989-06       Impact factor: 9.461
View more
  13 in total

1.  The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.

Authors:  J J Fung; M Eliasziw; S Todo; A Jain; A J Demetris; J P McMichael; T E Starzl; P Meier; A Donner
Journal:  J Am Coll Surg       Date:  1996-08       Impact factor: 6.113

2.  Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report.

Authors:  L A Mieles; J J Fung; I Yokoyama; J McCauley; N Singh; S Todo; R D Gordon; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  Effect of FK 506 on function of human islets of Langerhans.

Authors:  H L Rilo; Y Zeng; R Alejandro; P B Carroll; D Bereiter; R Venkataramanan; A G Tzakis; T E Starzl; C Ricordi
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

4.  FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication.

Authors:  P B Carroll; H Rilo; J Reyes; R Alejandro; Y Zeng; C Ricordi; A Tzakis; R Shapiro; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

5.  Kidney transplantation under FK 506 immunosuppression.

Authors:  R Shapiro; M Jordan; J Fung; J McCauley; J Johnston; Y Iwaki; A Tzakis; T Hakala; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

6.  Use of FK 506 in pediatric patients.

Authors:  A G Tzakis; J J Fung; S Todo; J Reyes; M Green; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

7.  Long-term insulin requirement after liver transplantation with FK 506 in American veterans.

Authors:  J Tabasco-Minguillan; L Mieles; P Carroll; J Gavaler; D H Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

8.  Adverse effects of FK 506 overdosage after liver transplantation.

Authors:  M Alessiani; U Cillo; J J Fung; W Irish; K Abu-Elmagd; A Jain; S Takaya; D Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

Review 9.  Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes.

Authors:  Vijay Shivaswamy; Brian Boerner; Jennifer Larsen
Journal:  Endocr Rev       Date:  2015-12-09       Impact factor: 19.871

Review 10.  Clinical islet cell transplantation. Are we there yet?

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1998-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.